Gamma-Aminobutyric Acid Promotes Beige Adipocyte Reconstruction by Modulating the Gut Microbiota in Obese Mice

• Published in: Nutrients Vol. 15; no. 2; p. 456
• Main Authors: Ma, Xiaoyi, Yan, Huanhuan, Hong, Shubin, Yu, Shuang, Gong, Yingying, Wu, Dide, Li, Yanbing, Xiao, Haipeng
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 15.01.2023; MDPI
• Subjects: 3-hydroxybutyric acid; Adipocytes; Adipocytes, Beige - metabolism; Animals; Antibiotics; Bacteroidetes; blood serum; Body fat; Cold; Data analysis; Diet; Diet, High-Fat; digestive system; Discriminant analysis; dysbiosis; Feces; Firmicutes; gamma-aminobutyric acid; Gastrointestinal Microbiome; Glucose; Gut microbiota; Humidity; inflammation; Insulin; intestinal microorganisms; Lipids; Magnetic resonance imaging; Medical research; Metabolism; Metabolites; metabolomics; Mice; Mice, Inbred C57BL; Mice, Obese; Microbiota; nucleotide sequences; Obesity; Obesity - metabolism; oxidation; RNA, Ribosomal, 16S; sequence analysis; Small intestine; Software; Thermogenesis; Weight control; weight loss; white adipose tissue; United States > US; China; beige adipose; GABA; white adipose; gut microbiota; obesity
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15020456

Given the increasing prevalence of obesity, the white-to-beige adipocyte conversion has attracted interest as a target for obesity treatment. Gamma-aminobutyric acid (GABA) treatment can reduce obesity, but the underlying mechanism remains unclear. Here, we aimed to investigate the mechanism by which GABA triggers weight loss by improving the beiging of inguinal white adipose tissue (iWAT) and the role of gut microbiota in this process. The results showed that GABA reduced body weight and adipose inflammation and promoted the expression of thermogenic genes in the iWAT. The 16S rRNA sequence analysis of gut microbiota showed that GABA treatment increased the relative abundance of Bacteroidetes, Akkermansia, and Romboutsia and reduced that of Firmicutes and Erysipelatoclostridium in obese mice. Additionally, serum metabolomic analysis revealed that GABA treatment increased 3-hydroxybutyrate and reduced oxidized lipid levels in obese mice. Spearman’s correlation analysis showed that Akkermansia and Romboutsia were negatively associated with the levels of oxidized lipids. Fecal microbiota transplantation analysis confirmed that the gut microbiota was involved in the white-to-beige adipocyte reconstruction by GABA. Overall, our findings suggest that GABA treatment may promote iWAT beiging through the gut microbiota in obese mice. GABA may be utilized to protect obese people against metabolic abnormalities brought on by obesity and gut dysbiosis.